KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Share-based Compensation (2016 - 2026)

AbbVie has reported Share-based Compensation over the past 14 years, most recently at $157.0 million for Q4 2025.

  • Quarterly Share-based Compensation fell 4.27% to $157.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $955.0 million through Dec 2025, up 4.83% year-over-year, with the annual reading at $955.0 million for FY2025, 4.83% up from the prior year.
  • Share-based Compensation was $157.0 million for Q4 2025 at AbbVie, down from $209.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $410.0 million in Q1 2025 and troughed at $107.0 million in Q2 2022.
  • The 5-year median for Share-based Compensation is $171.5 million (2023), against an average of $198.8 million.
  • Year-over-year, Share-based Compensation plummeted 32.7% in 2022 and then soared 67.29% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $129.0 million in 2021, then rose by 2.33% to $132.0 million in 2022, then dropped by 5.3% to $125.0 million in 2023, then soared by 31.2% to $164.0 million in 2024, then decreased by 4.27% to $157.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Share-based Compensation are $157.0 million (Q4 2025), $209.0 million (Q3 2025), and $179.0 million (Q2 2025).